Muscarinic type 1 receptors mediate part of nitric oxide's vagal facilitatory effect in the isolated innervated rat right atrium

Nitric Oxide - Biology and Chemistry

Volumn 16, Issue 1, 2007, Pages 110-117

  Hogan, K ^a   Markos, F ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Heart; Muscarinic receptors; Neuronal nitric oxide; Vagus

Indexed keywords

3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; ARGININE; ATENOLOL; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PARA FLUOROHEXAHYDROSILADIFENIDOL; PIRENZEPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HEART RIGHT ATRIUM; ISOLATED HEART; MALE; NERVE CONDUCTION; NONHUMAN; POSTGANGLIONIC NERVE; PREGANGLIONIC NERVE; PRIORITY JOURNAL; PULSE RATE; RAT; VAGUS NERVE; VAGUS NERVE STIMULATION;

ANALYSIS OF VARIANCE; ANIMALS; HEART ATRIA; MUSCARINIC ANTAGONISTS; NICOTINE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PIRENZEPINE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1;

EID: 33751431818     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2006.05.005     Document Type: Article

References (20)

1. Danson E.J., Choate J.K., and Paterson D.J. Cardiac nitric oxide: Emerging role for nNOS in regulating physiological function. Pharmacol. Ther. 106 1 (2005) 57-74
2. Markos F., Snow H.M., Kidd C., and Conlon K. Nitric oxide facilitates vagal control of heart rate via actions in the cardiac parasympathetic ganglia of the anaesthetised dog. Exp. Physiol. 87 1 (2002) 49-52
3. Sweeney C., and Markos F. The role of neuronal nitric oxide in the vagal control of cardiac interval of the rat heart in vitro. Auton. Neurosci. 111 2 (2004) 110-115
4. Heaton D.A., Golding S., Bradley C.P., Dawson T.A., Cai S., Channon K.M., and Paterson D.J. Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig. J. Mol. Cell Cardiol. 39 1 (2005) 159-164
5. Hassall C.J., Stanford S.C., Burnstock G., and Buckley N.J. Co-expression of four muscarinic receptor genes by the intrinsic neurons of the rat and guinea-pig heart. Neuroscience 56 4 (1993) 1041-1048
6. Hoover D.B., Baisden R.H., and Xi-Moy S.X. Localization of muscarinic receptor mRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. Circ. Res. 75 5 (1994) 813-820
7. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48 1 (1996) 113-178
8. Brodde O.E., and Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol. Rev. 51 4 (1999) 651-690
9. Olgart C., and Iversen H.H. Nitric oxide-dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine. Br. J. Pharmacol. 127 1 (1999) 309-313
10. Golkar L., Yarkony K.A., and Fryer A.D. Inhibition of neuronal M(2) muscarinic receptor function in the lungs by extracellular nitric oxide. Br. J. Pharmacol. 131 2 (2000) 312-318
11. Wang Z., Shi H., and Wang H. Functional M3 muscarinic acetylcholine receptors in mammalian hearts. Br. J. Pharmacol. 142 3 (2004) 395-408
12. M. De, B. Daly, Peripheral Arterial Chemoreceptors and Respiratory-Cardiovascular Integration, Oxford University Press, Appendix I, 1997, pp. 597-604.
13. Mourier G., Dutertre S., Fruchart-Gaillard C., Menez A., and Servent D. Chemical synthesis of MT1 and MT7 muscarinic toxins: Critical role of Arg-34 in their interaction with M1 muscarinic receptor. Mol. Pharmacol. 63 1 (2003) 26-35
14. Onali P., Adem A., Karlsson E., and Olianas M.C. The pharmacological action of MT-7. Life Sci. 76 14 (2005) 1547-1552
15. Karlsson E., Jolkkonen M., Mulugeta E., Onali P., and Adem A. Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie 82 9-10 (2000) 793-806
16. Ponicke K., Heinroth-Hoffmann I., and Brodde O.E. Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats. Br. J. Pharmacol. 138 1 (2003) 156-160
17. Willmy-Matthes P., Leineweber K., Wangemann T., Silber R.E., and Brodde O.E. Existence of functional M3-muscarinic receptors in the human heart. Naunyn Schmiedebergs Arch. Pharmacol. 368 4 (2003) 316-319
18. Conlon K., and Kidd C. Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. J. Auton. Nerv. Syst. 75 2-3 (1999) 136-146
19. Herring N., and Paterson D.J. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J. Physiol. 535 2 (2001) 507-518
20. Augelli-Szafran C.E., Jaen J.C., Moreland D.W., Nelson C.B., Penvose-Yi J.R., and Schwarz R.D. Identification and characterization of m4 selective muscarinic antagonists. Bioorg. Med. Chem. Lett. 8 15 (1998) 1991-1996